Related Experiment Videos
Early laryngeal cancer.
Russell W Hinerman1, William M Mendenhall, Robert J Amdur
1Department of Radiation Oncology, University of Florida Health Science Center, PO Box 100385, Gainesville, FL 32610-0385, USA. hinerrw@shands.ufl.edu
Current Treatment Options in Oncology
|June 12, 2002
Summary
For early-stage laryngeal cancer, radiation therapy and surgery offer high cure rates. Radiation is the preferred initial treatment for most early vocal cord cancers, with laser surgery for select cases.
Area of Science:
- Otolaryngology
- Radiation Oncology
- Surgical Oncology
Background:
- Early-stage laryngeal cancer presents distinct treatment considerations.
- Surgery and radiotherapy are established effective modalities for early laryngeal malignancies.
- Local control and cure rates are high for select patient groups.
Purpose of the Study:
- To outline current treatment strategies for early-stage laryngeal cancer at our institution.
- To compare the efficacy of radiation therapy versus surgical interventions for glottic and supraglottic cancers.
- To identify patient subsets suitable for specific organ-sparing procedures.
Main Methods:
- Review of treatment protocols for early-stage laryngeal cancer (T1/T2 vocal cord, Stage I/II supraglottic).
- Comparison of local control rates for radiation therapy, cordectomy, hemilaryngectomy, and transoral laser excision.
- Analysis of treatment selection criteria based on tumor stage, location, and organ preservation goals.
Main Results:
- Radiation therapy is the primary treatment for T1/T2 vocal cord cancers.
- Transoral laser excision is considered for well-defined T1 glottic tumors in the mid-cord.
- Stage I/II supraglottic cancers are managed with radiation or supraglottic laryngectomy; transoral laser excision is an alternative for selected lesions.
- Approximately 80% of patients receive initial irradiation.
Conclusions:
- Radiation therapy remains the cornerstone for early-stage vocal cord cancer treatment.
- Organ-sparing surgical options like transoral laser excision are valuable for select early laryngeal cancers.
- Multimodality treatment approaches ensure high rates of local control and cure while optimizing functional outcomes.